Page last updated: 2024-11-08

hafnia

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hafnia: A genus of straight, gram-negative bacterial rods which are facultatively anaerobic and motile by peritrichous flagella. This genus is found in human and animal feces, soil, water, and dairy products. It is an opportunistic pathogen in humans. (From Bergey's Manual of Determinative Bacteriology, 9th ed) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID292779
MeSH IDM0328452

Synonyms (30)

Synonym
hafnium oxide
hafnium(iv) oxide
hafnium dioxide
hafnia
nsc158931
12055-23-1
hafnium oxide (hfo2)
hafnium(iv) oxide, powder, 98%
hafnium(iv) oxide, >=99.95%
hafnium dioxide (hfo2)
dioxohafnium
37230-85-6
nsc 158931
hafnia (hfo2)
ec 235-013-2
hafnotrast
einecs 235-013-2
unii-3c4z4kg52t
AKOS015903694
hafnium(iv) oxide, spectrographic grade
mfcd00003565
hafnium(iv) oxide, pellets, diam. x thickness 9 mm x 4.2 mm
hafnium(iv) oxide, pellets, diam. x thickness 13 mm x 5 mm
DTXSID70893204
Q418740
niobium carbide (nbc) powder
hafnium oxide powder
D95076
CS-0198879
hafnium(iv) oxide, lump

Research Excerpts

Overview

Hafnia paralvei is a bacterium that can cause zoonoses. Hafnia genus is an opportunistic pathogen that has been implicated in both nosocomial and community-acquired infections.

ExcerptReferenceRelevance
"Hafnia paralvei is a bacterium that can cause zoonoses. "( Induction and Genomic Analysis of a Lysogenic Phage of Hafnia paralvei.
Li, D; Lin, W; Pan, L; Qin, W; Tong, Y; Xu, L; Zhan, P, 2022
)
2.41
"The Hafnia genus is an opportunistic pathogen that has been implicated in both nosocomial and community-acquired infections. "( Comparative genomic analysis of the Hafnia genus reveals an explicit evolutionary relationship between the species alvei and paralvei and provides insights into pathogenicity.
Du, Y; Huang, D; Liu, B; Qian, C; Wei, Y; Yang, P; Yin, Z; Yuan, C; Zhang, S, 2019
)
1.35

Toxicity

ExcerptReferenceRelevance
" The ToF-SIMS analysis indicated unique signatures of Br and P in the sample toxic to human cell lines suggesting a distinct synthesis was used for that sample which may have been accompanied by inhibitory impurities."( Cytotoxicity and physicochemical properties of hafnium oxide nanoparticles.
Barnes, C; Boitano, SA; Field, JA; Luna-Velasco, A; Ratner, BD; Shadman, F; Sierra-Alvarez, R, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (104)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (6.73)18.7374
1990's0 (0.00)18.2507
2000's11 (10.58)29.6817
2010's71 (68.27)24.3611
2020's15 (14.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 80.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index80.73 (24.57)
Research Supply Index4.69 (2.92)
Research Growth Index6.01 (4.65)
Search Engine Demand Index135.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (80.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.89%)5.53%
Reviews3 (2.83%)6.00%
Case Studies2 (1.89%)4.05%
Observational0 (0.00%)0.25%
Other99 (93.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]